The department has grappled with an officer's death and scrutiny around another's use of force in the past year.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...